<DOC>
	<DOCNO>NCT02967094</DOCNO>
	<brief_summary>Study design evaluate efficacy mucolytic solution ingest upper endoscopy visibility gastric mucosa .</brief_summary>
	<brief_title>Mucolytic Solution Before Upper Endoscopy</brief_title>
	<detailed_description>Residual gastric content contain mucus , bubble , bile food particle may limit visibility gastric mucosa therefore diagnostic yield upper endoscopy , especially case early neoplastic lesion . Data benefit peroral mucolytic solution administer upper endoscopy limit .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Expectorants</mesh_term>
	<criteria>age &gt; 18 year sign informed consent diagnostic gastroscopy age &lt; 18 year interventional gastroscopy know disease upper GI tract and/or history surgery GI tract gastroscopy indicate bleeding , dysphagia ileus liver cirrhosis general anesthesia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>